2023 Annual Meeting | C78 - Neurologic Intensive Care: Brain and Acute Spinal Cord Injury and Neuromuscular Disease

Date Monday 04/24/23

Time 07:00 AM - 09:00 AM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Jan Claassen, MD, PhD

Topic(s) Neuro Trauma and Critical Care

Learning Objectives Participants will gain insights into the practice of neurologic intensive care medicine including fundamental skills of diagnosis, management, and prognostication of acute neurologic injuries; and acquire knowledge about the approach to ICU management of patients with acute brain injuries such as elevation of intracranial pressure and herniation, diagnosis and ICU management of neuromuscular disorders and spinal cord injury, assessments and predictions, and ethical implications of caring for comatose patients

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Event Timeline
07:00 AM - 07:05 AM EST	Introduction	Introduction Jan Claassen, MD, PhD
07:05 AM - 07:40 AM EST	Speaker	Neuromuscular Disorders and Spinal Cord Injury in the ICU: Diagnosis, Management and Treatment Diana Greene-Chandos, MD
07:40 AM - 08:15 AM EST	Speaker	Acute Severe Brain Injury: Monitoring and Management Soojin Park, MD
08:15 AM - 08:50 AM EST	Speaker	Acute Severe Brain Injury: Prognostication and Goals of Care Discussions Jan Claassen, MD, PhD
08:50 AM - 09:00 AM EST	Discussion	Questions and Answers Jan Claassen, MD, PhD, Diana Greene-Chandos, MD, Soojin Park, MD

Faculty Disclosures
Jan Claassen, MD, PhD	Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.
Diana Greene-Chandos, MD	Dr. Greene-Chandos has nothing to disclose.
Soojin Park, MD	Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health.